Clinical Research and Pharmacovigilance
Clinical trials and pharmacovigilance are both built around patient safety, whether prior to, during or after the process of discovery. Translations that are accurate, reliable and which facilitate patient understanding are then an essential part of informed patient engagement.
The World Health Organisation (WHO) defines pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects as well as any other drug-related problems.
DWL provides translation solutions for pharmacovigilance during all stages of the product lifecycle, from research and development, to marketing authorisation and post-authorisation.
We frequently translate Adverse Drug Reaction (ADR) reports, discharge summaries and other documents related to drug safety.